phenyl acetate has been researched along with Cytokine Release Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almerie, MQ; Kerrigan, DD | 1 |
| Sanghai, N; Tranmer, GK | 1 |
| Citron, F; Deem, AK; Genovese, G; Perelli, L; Viale, A | 1 |
| Choudhir, G; Kumar, A; Mishra, A; Pathak, Y; Tripathi, V | 1 |
| Al-Gareeb, AI; Al-Kuraishy, HM; Almulaiky, YQ; Cruz-Martins, N; El-Saber Batiha, G | 1 |
1 review(s) available for phenyl acetate and Cytokine Release Syndrome
| Article | Year |
|---|---|
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity.
Topics: Acetates; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Cytokine Release Syndrome; Humans; Leukotriene Antagonists; Leukotrienes; Lung Diseases; Quinolines; Receptors, Leukotriene; Signal Transduction; Sulfides | 2021 |
4 other study(ies) available for phenyl acetate and Cytokine Release Syndrome
| Article | Year |
|---|---|
The association between obesity and poor outcome after COVID-19 indicates a potential therapeutic role for montelukast.
Topics: Acetates; Antiviral Agents; Betacoronavirus; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Cysteine Endopeptidases; Cytokine Release Syndrome; Drug Repositioning; Humans; Immunologic Factors; Inflammation; Leukotriene Antagonists; Obesity; Pandemics; Pneumonia, Viral; Quinolines; SARS-CoV-2; Sulfides; Viral Nonstructural Proteins | 2020 |
Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms.
Topics: Acetates; Age Factors; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Humans; Leukotriene Antagonists; NF-kappa B; Obesity; Quinolines; Respiratory Distress Syndrome; Severity of Illness Index; Sex Factors; Signal Transduction; Sulfides | 2020 |
Leukotrienes, a potential target for Covid-19.
Topics: Acetates; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Betacoronavirus; Coronavirus Infections; COVID-19; Cyclopropanes; Cytokine Release Syndrome; Humans; Hydroxyurea; Immunologic Factors; Indoles; Leukotrienes; Pandemics; Phenylcarbamates; Pneumonia, Viral; Quinolines; SARS-CoV-2; Severity of Illness Index; Sulfides; Sulfonamides; Tosyl Compounds | 2020 |
Rifampicin and Letermovir as potential repurposed drug candidate for COVID-19 treatment: insights from an in-silico study.
Topics: Acetates; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Drug Repositioning; Humans; Molecular Docking Simulation; Quinazolines; Rifampin; SARS-CoV-2; Viral Proteases | 2021 |